• レポートコード:D0JU09127 • 出版社/出版日:Transparency Market Research / 2020年2月7日 • レポート形態:英文、PDF、191ページ • 納品方法:Eメール • 産業分類:化学薬品&材料 |
Single User | ¥857,660 (USD5,795) | ▷ お問い合わせ |
Multi User | ¥1,301,660 (USD8,795) | ▷ お問い合わせ |
Corporate License | ¥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、ロードサイド薬物検査装置の世界市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場動向、市場概要、モダリティ別(ハンドヘルド、スタンドアロン)分析、物質別(薬物[テトラヒドロカンナビノール{THC}、コカイン、アンフェタミン、ベンゾジアゼピン、オピオイド、その他]、アルコール)分析、サンプル種類別(唾液、汗、尿、その他)分析、地域別分析、競争状況などの構成でお届けいたします。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場動向 ・市場概要 ・ロードサイド薬物検査装置の世界市場:モダリティ別(ハンドヘルド、スタンドアロン) ・ロードサイド薬物検査装置の世界市場:物質別(薬物[テトラヒドロカンナビノール{THC}、コカイン、アンフェタミン、ベンゾジアゼピン、オピオイド、その他]、アルコール) ・ロードサイド薬物検査装置の世界市場:サンプル種類別(唾液、汗、尿、その他) ・ロードサイド薬物検査装置の世界市場:地域別 ・競争状況 |
Roadside Drug Testing Devices Market – Scope of the Report
TMR’s report on the global roadside drug testing devices market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2019 to 2027. The report provides the revenue of the global roadside drug testing devices market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global roadside drug testing devices market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global roadside drug testing devices market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global roadside drug testing devices market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global roadside drug testing devices market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global roadside drug testing devices market.
The report delves into the competitive landscape of the global roadside drug testing devices market. Key players operating in the global roadside drug testing devices market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global roadside drug testing devices market that have been profiled in this report.
Key Questions Answered in Roadside Drug Testing Devices Market Report
What is the scope of growth of companies in the global roadside drug testing devices market?
What will be the Y-o-Y growth of the global roadside drug testing devices market between 2019 and 2027?
What is the influence of changing trends in technologies on the global roadside drug testing devices market?
Will North America continue to be the most profitable market for roadside drug testing devices providers?
Which factors will hamper the growth of the global roadside drug testing devices market during the forecast period?
Which are the leading companies in the global roadside drug testing devices market?
Research Methodology
A unique research methodology has been utilized by TMR to conduct a comprehensive research on the growth of the global roadside drug testing devices market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary sources referred by analysts during the production of the global roadside drug testing devices market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who have contributed to the production of TMR’s study on the global roadside drug testing devices market as primary sources.
These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from the roadside drug testing devices market leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global roadside drug testing devices market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on the prospects of the global roadside drug testing devices market more reliably and accurately.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Roadside Drug Testing Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Pricing Analysis
4.1.2. Industry Evolution/ Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.4. Global Roadside Drug Testing Devices Market Analysis and Forecast, 2017–2027
5. Market Outlook
5.1. Technological Advancements
5.2. Roadside Drugs Testing Programs, by Country/Region
5.3. Regulatory Scenario Assessment
5.4. Key Industry Events (mergers, acquisitions, collaborations, launch & approvals, etc.)
6. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Modality
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Modality, 2017–2027
6.3.1. Handheld
6.3.2. Standalone
6.4. Market Attractiveness Analysis, by Modality
7. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Substance
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Substance, 2017–2027
7.3.1. Drugs
7.3.1.1. Tetrahydrocannabinol (THC)
7.3.1.2. Cocaine
7.3.1.3. Amphetamine
7.3.1.4. Benzodiazepines
7.3.1.5. Opioids
7.3.1.6. Others
7.3.2. Alcohol
7.4. Market Attractiveness Analysis, by Substance
8. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Sample Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Sample Type, 2017–2027
8.3.1. Saliva
8.3.2. Sweat
8.3.3. Urine
8.3.4. Others
8.4. Market Attractiveness Analysis, by Substance
9. Global Roadside Drug Testing Devices Market Analysis and Forecast, by Region
9.1. Key Findings / Developments
9.2. Market Value Forecast, by Region, 2017–2027
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Roadside Drug Testing Devices Market Analysis and Forecast
10.1. Key Findings
10.2. Market Value Forecast, by Modality, 2017–2027
10.2.1. Handheld
10.2.2. Standalone
10.3. Market Value Forecast, by Substance, 2017–2027
10.3.1. Drugs
10.3.1.1. Tetrahydrocannabinol (THC)
10.3.1.2. Cocaine
10.3.1.3. Amphetamine
10.3.1.4. Benzodiazepines
10.3.1.5. Opioids
10.3.1.6. Others
10.3.2. Alcohol
10.4. Market Value Forecast, by Sample Type, 2017–2027
10.4.1. Saliva
10.4.2. Sweat
10.4.3. Urine
10.4.4. Others
10.5. Market Attractiveness Analysis, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Modality
10.6.2. By Substance
10.6.3. By Sample Type
10.6.4. By Country
11. Europe Roadside Drug Testing Devices Market Analysis and Forecast
11.1. Key Findings
11.2. Market Value Forecast, by Modality, 2017–2027
11.2.1. Handheld
11.2.2. Standalone
11.3. Market Value Forecast, by Substance, 2017–2027
11.3.1. Drugs
11.3.1.1. Tetrahydrocannabinol (THC)
11.3.1.2. Cocaine
11.3.1.3. Amphetamine
11.3.1.4. Benzodiazepines
11.3.1.5. Opioids
11.3.1.6. Others
11.3.2. Alcohol
11.4. Market Value Forecast, by Sample Type, 2017–2027
11.4.1. Saliva
11.4.2. Sweat
11.4.3. Urine
11.4.4. Others
11.5. Market Attractiveness Analysis, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Modality
11.6.2. By Substance
11.6.3. By Sample Type
11.6.4. By Country/Sub-region
12. Asia Pacific Roadside Drug Testing Devices Market Analysis and Forecast
12.1. Key Findings
12.2. Market Value Forecast, by Modality, 2017–2027
12.2.1. Handheld
12.2.2. Standalone
12.3. Market Value Forecast, by Substance, 2017–2027
12.3.1. Drugs
12.3.1.1. Tetrahydrocannabinol (THC)
12.3.1.2. Cocaine
12.3.1.3. Amphetamine
12.3.1.4. Benzodiazepines
12.3.1.5. Opioids
12.3.1.6. Others
12.3.2. Alcohol
12.4. Market Value Forecast, by Sample Type, 2017–2027
12.4.1. Saliva
12.4.2. Sweat
12.4.3. Urine
12.4.4. Others
12.5. Market Attractiveness Analysis, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Modality
12.6.2. By Substance
12.6.3. By Sample Type
12.6.4. By Country/Sub-region
13. Latin America Roadside Drug Testing Devices Market Analysis and Forecast
13.1. Key Findings
13.2. Market Value Forecast, by Modality, 2017–2027
13.2.1. Handheld
13.2.2. Standalone
13.3. Market Value Forecast, by Substance, 2017–2027
13.3.1. Drugs
13.3.1.1. Tetrahydrocannabinol (THC)
13.3.1.2. Cocaine
13.3.1.3. Amphetamine
13.3.1.4. Benzodiazepines
13.3.1.5. Opioids
13.3.1.6. Others
13.3.2. Alcohol
13.4. Market Value Forecast, by Sample Type, 2017–2027
13.4.1. Saliva
13.4.2. Sweat
13.4.3. Urine
13.4.4. Others
13.5. Market Attractiveness Analysis, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Substance
13.6.2. By Substance
13.6.3. By Sample Type
13.6.4. By Country/Sub-region
14. Middle East & Africa Roadside Drug Testing Devices Market Analysis and Forecast
14.1. Key Findings
14.2. Market Value Forecast, by Modality, 2017–2027
14.2.1. Handheld
14.2.2. Standalone
14.3. Market Value Forecast, by Substance, 2017–2027
14.3.1. Drugs
14.3.1.1. Tetrahydrocannabinol (THC)
14.3.1.2. Cocaine
14.3.1.3. Amphetamine
14.3.1.4. Benzodiazepines
14.3.1.5. Opioids
14.3.1.6. Others
14.3.2. Alcohol
14.4. Market Value Forecast, by Sample Type, 2017–2027
14.4.1. Saliva
14.4.2. Sweat
14.4.3. Urine
14.4.4. Others
14.5. Market Attractiveness Analysis, by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Modality
14.6.2. By Substance
14.6.3. By Sample Type
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis, by Company, 2018
15.3. Company Profiles
15.3.1. Abbott
15.3.1.1. Company Overview
15.3.1.2. Company Financials
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. Drägerwerk AG & Co. KGaA.
15.3.2.1. Company Overview
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. UriTox, LLC
15.3.3.1. Company Overview
15.3.3.2. Growth Strategies
15.3.3.3. SWOT Analysis
15.3.4. Oranoxis, Inc.
15.3.4.1. Company Overview
15.3.4.2. Growth Strategies
15.3.4.3. SWOT Analysis
15.3.5. Securetec
15.3.5.1. Company Overview
15.3.5.2. Growth Strategies
15.3.5.3. SWOT Analysis
15.3.6. CareHealth America
15.3.6.1. Company Overview
15.3.6.2. Growth Strategies
15.3.6.3. SWOT Analysis
15.3.7. MAVAND Solutions GmbH
15.3.7.1. Company Overview
15.3.7.2. Growth Strategies
15.3.7.3. SWOT Analysis
15.3.8. Pacific Data Systems Pty Ltd.
15.3.8.1. Company Overview
15.3.8.2. Growth Strategies
15.3.8.3. SWOT Analysis
List of TablesTable 01: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027
Table 02: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 03: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027
Table 04: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 05: Global Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 06: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027
Table 07: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 08: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027
Table 09: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 10: North America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 11: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027
Table 12: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 13: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027
Table 14: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 15: Europe Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 16: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027
Table 17: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 18: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027
Table 19: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 20: Asia Pacific Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027
Table 22: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 23: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027
Table 24: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 25: Latin America Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 26: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Substance, 2017–2027
Table 27: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Drugs, 2017–2027
Table 28: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Sample Type, 2017–2027
Table 29: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 30: Middle East & Africa Roadside Drug Testing Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027